ICPO Foundation Partners With Leading Pharmaceutical Company to Fund 130 Stipends to Professionals for the Academy's Online Education Program in the Field of Radiomolecular Precision Oncology (RPO) in the Asia Pacific Region.
Radiotheranostics has the power to offer novel patient-focused precision oncology treatments according to the principle: “We treat what we see and see what we treat”.
- Radiotheranostics has the power to offer novel patient-focused precision oncology treatments according to the principle: “We treat what we see and see what we treat”.
- Nevertheless, the broad adoption of Radiomolecular Precision Oncology faces substantial hurdles due to a critical shortage of skilled professionals.
- The ICPO Academy for Theranostics addresses this imperative by offering an extensive online educational program developed by the ICPO Foundation.
- The primary objective of this program is to disseminate knowledge in Radiomolecular Precision Oncology, thereby improving patient outcomes with radiopharmaceutical therapies.